Autism Drugs

Cambridge, MA-based Seaside Therapeutics recently announced that it has raised $30 million to pursue mid-stage clinical trial development on new therapies for Fragile X Syndrome and autism. CEO Randall L. Carpenter explained that the aim of the drug is to not only help symptoms of irritability found in many autistic children, but also to improve [...]

Researchers at the Massachusetts Institute of Technology have pinpointed two genes related to autistic like symptoms in mice.  The breakthrough brings hope that autism drugs could soon be developed that target the signaling mechanisms between the equivalent two genes in the human DNA.  The two genes involved are the PTEN gene, which encodes the phosphatase and [...]